Femara (letrozole) or Arimidex (anastrozole) for breast cancer
February 2001
More women will be taking Femara (letrozole) or Arimidex (anastrozole) for breast cancer.
Both are now approved for INITIAL therapy of metastatic breast cancer...as an alternative to tamoxifen.
Until now, tamoxifen was the gold standard for treating women with estrogen-receptor positive breast cancer. But Femara and Arimidex seem to work at least as well...if not better.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote